Info

Psychedelics Today

A show discussing the important academic and other research in the field of Psychedelics. We discuss how psychedelics relate to human potential and healing.
RSS Feed Subscribe in Apple Podcasts
Psychedelics Today
2022
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June
May


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
Mar 28, 2017
Download Kevin is a science writer, graduate student researcher and aspiring clinician, harm reduction educator and substance use recovery advocate. Kyle and Joe talk to him about loads of topics including early Iboga therapies, an early Boston Ibogaine Conference, his approach to journalism and his future aspirations to do future clinical work and research. Kevin's website

Kevin's writing

Staff Writer (Fall 2012–Spring 2013) - NuScience Magazine, Northeastern University


Links
Autism 20-25 mg Psilocybin 200 mcg - LSD A Conversation Between Gary Fisher and Myron Stolaroff (2004) - Psychedelic Salon 2009 Ibogaine Conference Northeastern University, Boston, Mass. Alicia Danforth Ph.D -Dissertation National Geographic - Breakthrough season 2

About Kevin:

Kevin graduated from Northeastern University in 2013 with a degree in neuroscience. As an undergraduate he completed an internship as a research assistant at Harvard Medical School working on the Phase 2 dose-response study investigating the therapeutic potential of MDMA-assisted psychotherapy for treatment of cancer related anxiety. Kevin was also one of the founders of the Northeastern chapter of Students for Sensible Drug Policy, and in 2009 the group hosted and co-sponsored the Boston Ibogaine Forum. He now lives in New York City where he is enrolled in a clinical psychology graduate program at The New School for Social Research and is pursuing a doctoral degree. Kevin has worked part-time for the Drug Policy Alliance, and also works as a writer covering topics related to psychedelic therapy, addiction, and mental health advocacy. His recent contributions include: New Scientist, Reason.com, Reset.me, Reality Sandwich, and VICE.com.
0 Comments
Adding comments is not available at this time.